Comparative efficacy and safety of oral ferrous fumarate versus intravenous iron sucrose in pregnancy with iron deficiency anemia: a prospective comparative study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20263029Keywords:
Adverse effects , Ferritin, Intravenous iron sucrose, Iron deficiency anemia, Oral iron, Pregnancy, Transferrin saturationAbstract
Background: Iron deficiency anemia (IDA) during pregnancy remains highly prevalent and is associated with maternal morbidity and adverse perinatal outcomes. Oral iron is widely used but limited by gastrointestinal intolerance and variable absorption, whereas intravenous (i.v.) iron sucrose may produce faster correction and improved iron stores. Objectives were to compare oral ferrous fumarate versus i.v. iron sucrose for improvement of hemoglobin and iron indices in pregnant women with IDA, and to compare adverse effects and pregnancy/neonatal outcomes.
Methods: In this prospective comparative interventional study, 164 pregnant women with biochemical evidence of iron deficiency were allocated to group A (oral ferrous fumarate 300 mg/day ≈100 mg elemental iron + folic acid; n=82) or group B (i.v. iron sucrose 200 mg on alternate days + folic acid; n=82). Hemoglobin and iron profile were assessed at baseline and repeated at 3 and 8 weeks. Adverse effects and obstetric/neonatal outcomes were documented. Between‑group comparisons used appropriate parametric/non‑parametric tests; p<0.05 was significant.
Results: Baseline characteristics and iron indices were comparable. Hemoglobin increased in both groups but was higher in group B at 3 weeks (10.05±0.73 versus 9.59±0.73 gm/dl; p<0.001) and 8 weeks (10.69±0.89 versus 10.32±0.77; p=0.006). Ferritin rose more in group B at 3 weeks (118.16±54.89 versus 58.87±16.99 ng/ml; p<0.001) and remained higher at 8 weeks (64.58±14.19 versus 56.59±14.82 ng/mL; p=0.001). Transferrin saturation improved more in group B at both follow‑ups (p<0.001). Oral iron caused more gastrointestinal adverse effects, whereas i.v. therapy showed more itching, thrombophlebitis and hypotension. Delivery and neonatal outcomes were comparable.
Conclusions: I.v. iron sucrose achieved faster and greater improvement in hemoglobin and iron stores with a route‑specific adverse‑effect profile, supporting its use in selected pregnant women needing rapid correction or with poor tolerance/adherence to oral iron.
References
Kuppusamy P, Prusty RK, Khan SA. Assessing the prevalence and predictors of anemia among pregnant women in India: findings from the India National Family Health Survey 2019-2021. Curr Med Res Opin. 2024;40(1):51-8.
Georgieff MK. Iron deficiency in pregnancy. Am J Obstet Gynecol. 2020;223(4):516-24.
Malinowski AK, Murji A. Iron deficiency and iron deficiency anemia in pregnancy. CMAJ. 2021;193(29):E1137-8.
World Health Organization. Guideline: Daily iron and folic acid supplementation in pregnant women. Geneva: World Health Organization; 2012.
Obianeli C, Afifi K, Stanworth S, Churchill D. Iron deficiency anaemia in pregnancy: a narrative review from a clinical perspective. Diagnostics. 2024;14(20):2306.
Neogi SB, Devasenapathy N, Singh R, Bhushan H, Shah D, Divakar H, et al. Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Glob Health. 2019;7(12):e1706-16.
Govindappagari S, Burwick RM. Treatment of iron deficiency anemia in pregnancy with intravenous versus oral iron: a systematic review and meta-analysis. Am J Perinatol. 2019;36(4):366-76.
Anjum S, Sweta, Saini V. Comparative study to evaluate intravenous iron sucrose with oral ferrous sulphate for treatment of anemia in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2024;13(11):3171-4.
Kriplani A, Mahey R, Dash BB, Kulshreshta V, Agarwal N, Bhatla N. Intravenous iron sucrose therapy for moderate to severe anemia in pregnancy. Indian J Med Res. 2013;138(1):78-82.
Neeru S, Nair NS, Rai L. Iron sucrose versus oral iron therapy in pregnancy anemia. Indian J Community Med. 2012;37(4):214-8.
Froessler B, Cocchiaro C, Saadat-Gilani K, Hodyl N, Dekker G. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial. J Matern Fet Neonat Med. 2013;26(7):654-9.
Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A. Intravenous versus oral iron for the treatment of anemia in pregnancy: a randomized trial. Obstet Gynecol. 2005;106(6):1335-40.
Pasricha SR, Mwangi MN, Moya E, Ataide R, Mzembe G, Harding R, et al. Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial. Lancet. 2023;401(10388):1595-609.
Afolabi BB, Babah OA, Adeyemo TA, Balogun M, Banke-Thomas A, Abioye AI, et al. Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial. Lancet Glob Health. 2024;12(10):e1649-59.
Hansen R, Sommer VM, Pinborg A, Krebs L, Thomsen LL, Moos T, et al. Intravenous ferric derisomaltose versus oral iron for persistent iron deficient pregnant women: a randomised controlled trial. Arch Gynecol Obstet. 2023;308(4):1165-73.
Banerjee A, Athalye S, Shingade P, Khargekar V, Mahajan N, Madkaikar M, et al. Efficacy of daily versus intermittent oral iron supplementation for prevention of anaemia among pregnant women: a systematic review and meta-analysis. EclinMed. 2024;74.
Stanworth SJ, Churchill D, Sweity S, Holmes T, Hudson C, Brown R, et al. The impact of different doses of oral iron supplementation during pregnancy: a pilot randomized trial. Blood Adv. 2024;8(21):5683-94.
Pandey AK, Gautam D, Tolani H, Neogi SB. Clinical outcome post treatment of anemia in pregnancy with intravenous versus oral iron therapy: a systematic review and meta-analysis. Sci Rep. 2024;14(1):179.
Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proceed. 2015;90(1):12-23.
Perewusnyk G, Huch R, Huch A, Breymann C. Parenteral iron therapy in obstetrics: 8 years’ experience with iron-sucrose complex. Br J Nutr. 2002;88(1):3-10.
Qayyum J, Farhan SQ, Qureshi QU, Jamali AG, Fatima A, Imtiaz B, et al. Comparing the treatment outcomes of oral and injectable iron therapies for anemia in pregnancy: a meta-analysis. Cureus. 2025;17(2).
Rosson S, Pavord S. Understanding hepcidin for iron management in pregnancy. Transfus Med. 2025;35(2):109-15.
Benson AE, Lo JO, Achebe MO, Aslan JS, Auerbach M, Bannow BT, et al. Management of iron deficiency in children, adults, and pregnant individuals: evidence-based and expert consensus recommendations. Lancet Haematol. 2025;12(5):e376-88.
World Health Organization. WHO global anaemia estimates: key findings, 2025. World Health Organization; 2025.
World Health Organization. Daily iron and folic acid supplementation during pregnancy. 2024. Available at: http://www. who. int/elena/titles/guidance_summaries/daily_iron_pregnancy/en. Accessed on 31 March 2026.
Downloads
Published
How to Cite
Issue
Section
